Trace Amine Associate Receptor 1 (TAAR1) as a New Target for the Treatment of Cognitive Dysfunction in Alzheimer’s DiseaseDamiana Leo(Inserm), Laurence Ris(University of Mons)International Journal of Molecular SciencesJuly 15, 202210.3390/ijms23147811Cited by 19SaveCiteExport RISWatch citationsRelated PapersPronounced Hyperactivity, Cognitive Dysfunctions, and BDNF Dysregulation in Dopamine Transporter Knock-out Rats|Journal of Neuroscience|2018|202Biochemical and Functional Characterization of the Trace Amine-Associated Receptor 1 (TAAR1) Agonist RO5263397.|ORBi UMONS|2018|0